Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication?
Weismantel
D
D
Michigan State University, East Lansing, USA. david.weismantel@ht.msu.edu
D000077407:Cilostazol; D019317:Evidence-Based Medicine; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy* / Q000503:physiopathology; D010431:Pentoxifylline / Q000494:pharmacology / Q000627:therapeutic use*; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016138:Walking
D013777:Tetrazoles; D014665:Vasodilator Agents; D000077407:Cilostazol; D010431:Pentoxifylline